Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: A randomized study

International Urogynecology Journal

Volumn 23, Issue 12, 2012, Pages 1707-1713

  De Vita, Davide ^a   Giordano, Salvatore ^b  

^a Obstetrics and Gynecologyc Department S Maria della Speranza   (Italy)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chondroitin sulfate; Cystitis; Hyaluronic acid; Intravesical instillation; Recurrent urinary tract infections

Indexed keywords

BIOMATERIAL; CHONDROITIN SULFATE PLUS HYALURONIC ACID; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG; CHONDROITIN SULFATE; HYALURONIC ACID; IMMUNOLOGICAL ADJUVANT;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BLADDER CAPACITY; BLADDER IRRIGATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; CYSTOMETRY; FEMALE; FOLLOW UP; HUMAN; INFECTION PREVENTION; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; SEXUAL FUNCTION; SYMPTOM ASSESSMENT; AGED; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; INTRAVESICAL DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; PAIN ASSESSMENT; RECURRENT DISEASE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; AGED; BACTERIAL INFECTIONS; CHONDROITIN SULFATES; CYSTITIS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYALURONIC ACID; MIDDLE AGED; PAIN MEASUREMENT; QUALITY OF LIFE; RECURRENCE;

EID: 84877602976     PISSN: 09373462     EISSN: 14333023     Source Type: Journal    
DOI: 10.1007/s00192-012-1794-z     Document Type: Article

References (35)

1. Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity and economic costs. Am J Med 113:5S-13S (Pubitemid 34756640)
2. Ronald A (2002) The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 113:14S-19S (Pubitemid 34756641)
3. Chung A, Arianayagam M, Rashid P (2010) Bacterial cystitis in women. Aust Fam Physician 39(5):295-298
4. Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P et al (2000) Risk factors for second urinary tract infection among college women. Am J Epidemiol 151:1194-1205 (Pubitemid 30451952)
5. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA (1992) Reduction of bacteriuria and pyuria after ingestion of cranberry juice. J Am Med Assoc 271:751-754 (Pubitemid 24074521)
6. Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329:753-756 (Pubitemid 23262529)
7. Reid G (1999) The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 65:3763-3766
8. Schulman CC, Corbusier A, Michiels H, Taenzer HJ (1993) Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study. J Urol 150:917-921 (Pubitemid 23241299)
9. Kruze D, Holzbecher K, Andrial M, Bossart W (1989) Urinary antibody response after immunisation with a vaccine against urinary tract infection. Urol Res 17:361-366 (Pubitemid 19278189)
10. Schilling JD, Mulvey MA, Hultgren SJ (2001) Dynamic interactions between host and pathogen during acute urinary tract infections. Urology 57:56-61 (Pubitemid 33733968)
11. Reid G (1999) Current scientific understanding of urinary tract infections in women: an overview. World J Urol 17:336-338
12. Gupta K, Stamm WE (1999) Pathogenesis and management of recurrent urinary tract infections in women. World J Urol 17:415-420
13. Poggi MM, Johnstone PAS, Conner RJ (2000) Glycosaminoglycan content of human bladders: a method of analysis using coldcup biopsies. Urol Oncol 5:234-237
14. Morales A, Emerson L, Nickel JC (1997) Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 49:111-113 (Pubitemid 27193962)
15. Parsons CL (1997) Epithelial coating techniques in the treatment of interstitial cystitis. Urology 49:100-104 (Pubitemid 27193959)
16. Daha LK, Riedl CR, Hohlbrugger G, Knoll M, Engelhardt PF, Pflüger H (2003) Comparative assessment of maximal bladder capacity, 0.9% NaCl versus 0.2 M KCl, for diagnosis of interstitial cystitis: prospective controlled study. J Urol 170:807-809 (Pubitemid 36999562)
17. Shao Y, Shen ZJ, Rui WB, Zhou WL (2010) Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Urology 75(3):547-550
18. Porru D, Leva F, Parmigiani A, et al (2011) Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. Int Urogynecol. doi: 10.1007/s00192-011-1546-5
19. Constantinides C, Manousakas T, Nikolopoulos P, Stanitsas A, Haritopoulos K, Giannopoulos A (2004) Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int 93(9):1262-1266 (Pubitemid 38823949)
20. Lipovac M, Kurz C, Reithmayr F, Verhoeven HC, Huber JC, Imhof M (2007) Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Int J Gynaecol Obstet 96(3):192-195 (Pubitemid 46281918)
21. Damiano R, Quarto G, Bava I et al (2011) Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol 59(4):645-651
22. Gillenwater JY, Wein AJ (1987) Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 140(1):203-206
23. Ronald AR, Harding CK, Mathias R, Wong CK, Muir P (1975) Prophylaxis of recurring urinary tract infection in females: a comparison of nitrofurantoin with trimethoprim-sulfamethoxazole. Can Med Assoc J 112(13 Spec No):13-16
24. Salomon J, Denys P, Merle C, Chartier-Kastler E, Perronne C, Gaillard JL, Bernard L (2006) Prevention of urinary tract infection in spinal cord-injured patients: safety and efficacy of a weekly oral cyclic antibiotic (WOCA) programme with a 2 year follow-up-an observational prospective study. J Antimicrob Chemother 57(4):784-788
25. Ito T, Tomoe H, Ueda T, Yoshimura N, Sant G, Hanno P (2003) Clinical symptoms scale for interstitial cystitis for diagnosis and for following the course of the disease. Int J Urol 10:S24-26 (Pubitemid 37500724)
26. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104(12):1374-1379 (Pubitemid 27517634)
27. Figueiredo AB, Palma P, Riccetto C, Herrmann V, Dambros M, Capmartin R (2011) Clinical and urodynamic experience with intravesical hyaluronic acid in painful bladder syndrome associated with interstitial cystitis. Actas Urol Esp 35(3):184-7
28. Leppilahti M, Hellström P, Tammela TL (2002) Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60(1):46-51 (Pubitemid 34722944)
29. Lee DG, Cho JJ, Park HK et al (2010) Preventive effects of hyaluronic acid on Escherichia coli-induced urinary tract infection in rat. Urology 75(4):949-954
30. Fraser MO, Lavelle JP, Sacks MS, Chancellor MB (2002) The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy. Rev Urol 4(1):1-11
31. Schulz A, Vestweber AM, Dressler D (2009) Anti-inflammatory action of a hyaluronic acid-chondroitin sulfate preparation in an in vitro bladder model. Aktuelle Urol 40(2):109-12
32. Southgate J, Varley CL, Garthwaite MA, Hinley J, Marsh F, Stahlschmidt J et al (2007) Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int 99(6):1506-1516 (Pubitemid 47164804)
33. Engelhardt PF, Morakis N, Daha LK, Esterbauer B, Riedl CR (2010) Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 22(4):401-405
34. Burkhard FC, Blick N, Hochreiter WW, Studer UE (2004) Urinary urgency and frequency, and chronic urethral and/or pelvic pain in females. Can doxycycline help? J Urol 172(1):232-235
35. Hooton TM (2001) Recurrent urinary tract infection in women. Int J Antimicrob Agents 17:259-268 (Pubitemid 32288741)